Loading…

Ciltacabtagene Autoleucel (Cilta-cel), a BCMA-Directed CAR-T Cell Therapy, in Patients with Multiple Myeloma (MM) and Early Relapse after Initial Therapy: CARTITUDE-2 Cohort B 18-Month Follow-up

Saved in:

Bibliographic Details
Published in:	Blood 2022-11, Vol.140 (Supplement 1), p.7536-7537
Main Authors:	Van De Donk, Niels WCJ, Agha, Mounzer, Cohen, Adam D, Cohen, Yael C, Anguille, Sébastien, Kerre, Tessa, Roeloffzen, Wilfried W.H., Schecter, Jordan M, De Braganca, Kevin C, Jackson, Carolyn C, Varsos, Helen, Mistry, Pankaj, Roccia, Tito, Xu, Xiaoying, Li, Katherine, Zudaire, Enrique, Corsale, Christina, Akram, Muhammad, Geng, Dong, Pacaud, Lida, Sonneveld, Pieter, Zweegman, Sonja
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!